Keros Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $23.00K, a 35.29% increase year-over-year.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $7.00K, a 75.00% increase year-over-year.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $2.00K, a 99.80% decline year-over-year.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $17.00K, a 99.43% decline year-over-year.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $150.00K, a 98.76% decline from fiscal 2024.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $12.14M, a 276.47% increase from fiscal 2023.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $3.23M, a 294.25% increase from fiscal 2022.
- Keros Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $818.00K, a 115.83% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $23.00K 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $7.00K 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $150.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $17.00K 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $4.00K 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $12.14M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $1.01M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $2.97M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $5.72M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $3.23M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $311.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $1.74M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $370.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $818.00K 10-K · filed 2025-02-26 | |
| 2022-09-30 | $96.00K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $502.00K 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $118.00K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $379.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $35.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $57.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $42.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $38.00K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $9.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $9.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $13.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $14.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $7.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $3.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |